Dyslipidemia Stocks List

Dyslipidemia Stocks Recent News

Date Stock Title
May 31 VKTX Here's Why Viking Therapeutics, Inc. (VKTX) Gained But Lagged the Market Today
May 31 VKTX Here's How Much You Would Have Made Owning Viking Therapeutics Stock In The Last 5 Years
May 31 IONS Europe Approves Biogen's Tofersen For Adult Patients With Rare Type Of Neurodegenerative Disorder
May 31 ABT The Most Profitable Biotechnology Company in the World
May 31 IONS Ionis hereditary angioedema therapy succeeds in late-stage trials
May 31 IONS Ionis presents positive results from OASIS-HAE and OASISplus studies of investigational medicine donidalorsen in patients with hereditary angioedema
May 30 ABT Abbott (ABT) Rises As Market Takes a Dip: Key Facts
May 30 VKTX Viking Therapeutics to Participate at Upcoming Investor Conferences
May 30 ARGX After Biohaven Kerfuffle, Immunovant Dives On A Surprise Delay
May 30 ABT Should Abbott and DexCom Investors Be Worried About Vertex Pharmaceuticals?
May 29 ABT Implied Volatility Surging for Abbot Laboratories (ABT) Stock Options
May 29 ARGX Biohaven Stock Stumbles As Protein-Degrading Drug Falls Short Of Expectations In Early-Stage Study
May 29 ARGX Biohaven Crashes After Protein-Degrading Drug Misses Expectations; Immunovant, Argenx Jump
May 29 MDGL Madrigal Pharmaceuticals to Present Multiple Rezdiffra™ (resmetirom) and Health Economics Outcomes Research Abstracts in NASH/MASH at the EASL Congress
May 28 IONS Ionis: Tough Run For Share Price Belies Multiple Reasons For Optimism
May 28 VKTX Wall Street Analysts Think Viking Therapeutics (VKTX) Is a Good Investment: Is It?
May 28 IONS Ionis to hold donidalorsen Phase 3 data webcast
May 27 VKTX This Biotech Stock is a “Strong Buy” According to Raymond James
May 26 VKTX If You'd Invested $100 in Viking Therapeutics Stock 2 Years Ago, Here's How Much You'd Have Today
May 25 VKTX 3 Biotech Stocks That Could Be Millionaire-Makers: May Edition
Dyslipidemia

Dyslipidemia is an abnormal amount of lipids (e.g. triglycerides, cholesterol and/or fat phospholipids) in the blood. In developed countries, most dyslipidemias are hyperlipidemias; that is, an elevation of lipids in the blood. This is often due to diet and lifestyle. Prolonged elevation of insulin levels can also lead to dyslipidemia. Likewise, increased levels of O-GlcNAc transferase (OGT) may cause dyslipidemia.

Browse All Tags